🇺🇸 FDA
Pipeline program

MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine

MEQ00073

Phase 3 small_molecule active

Quick answer

MenQuadfi solution for injection Meningococcal Group A, C, W and Y conjugate vaccine for Meningococcal infection is a Phase 3 program (small_molecule) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pasteur
Indication
Meningococcal infection
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials